A single MXene-based optical gate switches between seven Boolean logic functions via voltage, enabling trainable photonic ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
Hans-Gerd Janssen reflects on the importance of the Riva Conference conference to advance his expertise in separation science ...
Researchers developed a holographic data storage approach that stores and retrieves information in three dimensions by ...
Morning Overview on MSN
Study confirms "dark points" in light waves can move faster than light
Physicists have directly tracked tiny points of darkness in laser light racing faster than light itself, without breaking ...
RLS-1496 was well-tolerated, with no serious adverse events (AEs) and no discontinuations due to AEs or tolerability issues during the 4-week study In psoriasis patients: Dose-dependent target ...
Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 March 25, 2026 8:30 AM EDT Anupam Rama - JPMorgan Chase & Co, Research Division Konstantinos Biliouris - Oppenheimer & ...
USA: Researchers have found in a new study that treatment with Anifrolumab significantly reduced urinary biomarkers of renal histologic activity in patients with Lupus Nephritis compared with placebo.
A new programmable metasurface performs dynamic beamforming and radar cross-section reduction across five frequency bands in ...
Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.
Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 30, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results